Editorial: Considering plant metabolites and their synthetic derivatives as candidates for the development of drugs against multidrug resistant (MDR) tumors

Autores
Rijo, Patricia; Athanassopoulos, Constantinos M.; Carpinella, María Cecilia
Año de publicación
2022
Idioma
español castellano
Tipo de recurso
artículo
Estado
versión aceptada
Descripción
Despite the great benefits of chemotherapy, the ability of tumor cells to acquire crossresistance to multiple antineoplastic drugs (MDR) results in a drastic reduction in the efficacy of these agents. Of greatest concern is the consequent failure in clinical practice, which remains one of the major barriers to successful cancer treatment. To improve patient outcome, novel efficacious anti-cancer agents or approaches to reverse MDR are necessary. Plants have been an endless and vital source of pharmacologically active compounds, many of which are widely used in cancer therapies, not only to control tumor cells, but also to increase their sensitivity to chemotherapeutic agents. The structural diversity and array of biological properties of plant-derived metabolites, in particular against tumors, make these strong candidates to combat MDR cells or establish their scaffolds as a valuable base for the synthesis of derivatives. This enormous potential of plants to tackle MDR tumors encouraged us to publish this Research Topic to display and discuss the cutting-edge research in the field. As editors, it was a pleasure to review a wide range of fascinating articles with different perspectives, and we summarize here the main findings of accepted articles.
Fil: Rijo, Patricia. Universidade Lusófona Research Center for Biosciences & Health Technologies; Portugal
Fil: Athanassopoulos, Constantinos M. University of Patras; Grecia
Fil: Carpinella, María Cecilia. Universidad Católica de Córdoba. Facultad de Ciencias Químicas; Argentina
Fuente
Rijo, Patricia, Athanassopoulos, Constantinos M. ORCID: https://orcid.org/0000-0002-7549-1911 and Carpinella, María Cecilia ORCID: https://orcid.org/0000-0001-5553-1851 (2022) Editorial: Considering plant metabolites and their synthetic derivatives as candidates for the development of drugs against multidrug resistant (MDR) tumors. Frontiers in pharmacology. 01-02. ISSN 1663-9812
Materia
QD Química
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
Repositorio
Producción Académica (UCC)
Institución
Universidad Católica de Córdoba
OAI Identificador
oai:pa.bibdigital.uccor.edu.ar:3650

id PAUCC_fd17e9b567c690844cb2b0eeb8695dee
oai_identifier_str oai:pa.bibdigital.uccor.edu.ar:3650
network_acronym_str PAUCC
repository_id_str 2718
network_name_str Producción Académica (UCC)
spelling Editorial: Considering plant metabolites and their synthetic derivatives as candidates for the development of drugs against multidrug resistant (MDR) tumorsRijo, PatriciaAthanassopoulos, Constantinos M.Carpinella, María CeciliaQD QuímicaDespite the great benefits of chemotherapy, the ability of tumor cells to acquire crossresistance to multiple antineoplastic drugs (MDR) results in a drastic reduction in the efficacy of these agents. Of greatest concern is the consequent failure in clinical practice, which remains one of the major barriers to successful cancer treatment. To improve patient outcome, novel efficacious anti-cancer agents or approaches to reverse MDR are necessary. Plants have been an endless and vital source of pharmacologically active compounds, many of which are widely used in cancer therapies, not only to control tumor cells, but also to increase their sensitivity to chemotherapeutic agents. The structural diversity and array of biological properties of plant-derived metabolites, in particular against tumors, make these strong candidates to combat MDR cells or establish their scaffolds as a valuable base for the synthesis of derivatives. This enormous potential of plants to tackle MDR tumors encouraged us to publish this Research Topic to display and discuss the cutting-edge research in the field. As editors, it was a pleasure to review a wide range of fascinating articles with different perspectives, and we summarize here the main findings of accepted articles.Fil: Rijo, Patricia. Universidade Lusófona Research Center for Biosciences & Health Technologies; PortugalFil: Athanassopoulos, Constantinos M. University of Patras; GreciaFil: Carpinella, María Cecilia. Universidad Católica de Córdoba. Facultad de Ciencias Químicas; Argentina2022-12-07info:eu-repo/semantics/articleinfo:eu-repo/semantics/acceptedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfhttp://pa.bibdigital.ucc.edu.ar/3650/1/A_Rijo_Athanassopoulos_Carpinella.pdf Rijo, Patricia, Athanassopoulos, Constantinos M. ORCID: https://orcid.org/0000-0002-7549-1911 <https://orcid.org/0000-0002-7549-1911> and Carpinella, María Cecilia ORCID: https://orcid.org/0000-0001-5553-1851 <https://orcid.org/0000-0001-5553-1851> (2022) Editorial: Considering plant metabolites and their synthetic derivatives as candidates for the development of drugs against multidrug resistant (MDR) tumors. Frontiers in pharmacology. 01-02. ISSN 1663-9812 reponame:Producción Académica (UCC)instname:Universidad Católica de Córdobaspahttp://pa.bibdigital.ucc.edu.ar/3650/info:eu-repo/semantics/altIdentifier/doi/https://doi.org/10.3389/fphar.2022.1108252info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es2025-11-27T10:18:25Zoai:pa.bibdigital.uccor.edu.ar:3650instacron:UCCInstitucionalhttp://pa.bibdigital.uccor.edu.ar/Universidad privadaNo correspondehttp://pa.bibdigital.uccor.edu.ar/cgi/oai2bibdir@uccor.edu.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:27182025-11-27 10:18:26.075Producción Académica (UCC) - Universidad Católica de Córdobafalse
dc.title.none.fl_str_mv Editorial: Considering plant metabolites and their synthetic derivatives as candidates for the development of drugs against multidrug resistant (MDR) tumors
title Editorial: Considering plant metabolites and their synthetic derivatives as candidates for the development of drugs against multidrug resistant (MDR) tumors
spellingShingle Editorial: Considering plant metabolites and their synthetic derivatives as candidates for the development of drugs against multidrug resistant (MDR) tumors
Rijo, Patricia
QD Química
title_short Editorial: Considering plant metabolites and their synthetic derivatives as candidates for the development of drugs against multidrug resistant (MDR) tumors
title_full Editorial: Considering plant metabolites and their synthetic derivatives as candidates for the development of drugs against multidrug resistant (MDR) tumors
title_fullStr Editorial: Considering plant metabolites and their synthetic derivatives as candidates for the development of drugs against multidrug resistant (MDR) tumors
title_full_unstemmed Editorial: Considering plant metabolites and their synthetic derivatives as candidates for the development of drugs against multidrug resistant (MDR) tumors
title_sort Editorial: Considering plant metabolites and their synthetic derivatives as candidates for the development of drugs against multidrug resistant (MDR) tumors
dc.creator.none.fl_str_mv Rijo, Patricia
Athanassopoulos, Constantinos M.
Carpinella, María Cecilia
author Rijo, Patricia
author_facet Rijo, Patricia
Athanassopoulos, Constantinos M.
Carpinella, María Cecilia
author_role author
author2 Athanassopoulos, Constantinos M.
Carpinella, María Cecilia
author2_role author
author
dc.subject.none.fl_str_mv QD Química
topic QD Química
dc.description.none.fl_txt_mv Despite the great benefits of chemotherapy, the ability of tumor cells to acquire crossresistance to multiple antineoplastic drugs (MDR) results in a drastic reduction in the efficacy of these agents. Of greatest concern is the consequent failure in clinical practice, which remains one of the major barriers to successful cancer treatment. To improve patient outcome, novel efficacious anti-cancer agents or approaches to reverse MDR are necessary. Plants have been an endless and vital source of pharmacologically active compounds, many of which are widely used in cancer therapies, not only to control tumor cells, but also to increase their sensitivity to chemotherapeutic agents. The structural diversity and array of biological properties of plant-derived metabolites, in particular against tumors, make these strong candidates to combat MDR cells or establish their scaffolds as a valuable base for the synthesis of derivatives. This enormous potential of plants to tackle MDR tumors encouraged us to publish this Research Topic to display and discuss the cutting-edge research in the field. As editors, it was a pleasure to review a wide range of fascinating articles with different perspectives, and we summarize here the main findings of accepted articles.
Fil: Rijo, Patricia. Universidade Lusófona Research Center for Biosciences & Health Technologies; Portugal
Fil: Athanassopoulos, Constantinos M. University of Patras; Grecia
Fil: Carpinella, María Cecilia. Universidad Católica de Córdoba. Facultad de Ciencias Químicas; Argentina
description Despite the great benefits of chemotherapy, the ability of tumor cells to acquire crossresistance to multiple antineoplastic drugs (MDR) results in a drastic reduction in the efficacy of these agents. Of greatest concern is the consequent failure in clinical practice, which remains one of the major barriers to successful cancer treatment. To improve patient outcome, novel efficacious anti-cancer agents or approaches to reverse MDR are necessary. Plants have been an endless and vital source of pharmacologically active compounds, many of which are widely used in cancer therapies, not only to control tumor cells, but also to increase their sensitivity to chemotherapeutic agents. The structural diversity and array of biological properties of plant-derived metabolites, in particular against tumors, make these strong candidates to combat MDR cells or establish their scaffolds as a valuable base for the synthesis of derivatives. This enormous potential of plants to tackle MDR tumors encouraged us to publish this Research Topic to display and discuss the cutting-edge research in the field. As editors, it was a pleasure to review a wide range of fascinating articles with different perspectives, and we summarize here the main findings of accepted articles.
publishDate 2022
dc.date.none.fl_str_mv 2022-12-07
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/acceptedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str acceptedVersion
dc.identifier.none.fl_str_mv http://pa.bibdigital.ucc.edu.ar/3650/1/A_Rijo_Athanassopoulos_Carpinella.pdf
url http://pa.bibdigital.ucc.edu.ar/3650/1/A_Rijo_Athanassopoulos_Carpinella.pdf
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv http://pa.bibdigital.ucc.edu.ar/3650/
info:eu-repo/semantics/altIdentifier/doi/https://doi.org/10.3389/fphar.2022.1108252
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv Rijo, Patricia, Athanassopoulos, Constantinos M. ORCID: https://orcid.org/0000-0002-7549-1911 <https://orcid.org/0000-0002-7549-1911> and Carpinella, María Cecilia ORCID: https://orcid.org/0000-0001-5553-1851 <https://orcid.org/0000-0001-5553-1851> (2022) Editorial: Considering plant metabolites and their synthetic derivatives as candidates for the development of drugs against multidrug resistant (MDR) tumors. Frontiers in pharmacology. 01-02. ISSN 1663-9812
reponame:Producción Académica (UCC)
instname:Universidad Católica de Córdoba
reponame_str Producción Académica (UCC)
collection Producción Académica (UCC)
instname_str Universidad Católica de Córdoba
repository.name.fl_str_mv Producción Académica (UCC) - Universidad Católica de Córdoba
repository.mail.fl_str_mv bibdir@uccor.edu.ar
_version_ 1849951348843347968
score 13.011256